Overall rank by patents
#26,596
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H02H (EMERGENCY PROTECTIVE CIRCUIT ARRANGEMENTS).
The verdict
Intelesol holds 10 US patents across 7 technology areas, rank #26,596 of 50,000 tracked assignees.
Intelesol, Llc has been granted 10 US utility patents between 2020 and 2023, placing Intelesol, Llc at rank #26,596 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in H02H (EMERGENCY PROTECTIVE CIRCUIT ARRANGEMENTS). As a US Corporation, Intelesol, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Intelesol sits between Insights International Holdings, Llc (10 patents, rank #26,592) and Interface Biologics, Inc. (10 patents, rank #26,600) - the closest US assignees by grant volume. The composite Innovation Score of 39.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Intelesol, Llc's 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Intelesol, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Insights International Holdings, LLC
10 patents
Inspirna, Inc.
10 patents
IntSights Cyber Intelligence Ltd.
10 patents
Intel Germany GmbH & Co. KG
10 patents
Intelligent Abatement, LLC
10 patents
Intellipharmaceutics Corp.
10 patents
Interacoustics A/S
10 patents
Interface Biologics, Inc.
10 patents
Intelesol, LLC
10 patents
What this shows Intelesol holds 10 patents at rank #26,596, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Intelesol's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 39% higher than 61% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 10.0% |
| 2021 | 3 | 30.0% |
| 2022 | 2 | 20.0% |
| 2023 | 4 | 40.0% |
Top 7 of 7 technology areas
Overall rank by patents
#26,596
Across all tracked assignees
39.2 out of 100
How to use this portfolio
Intelesol's 10 grants land it in the top 39% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.